Inventor · disambiguated record
Mark Obukowicz
Also filed as: OBUKOWICZ MARK · OBUKOWICZ MARK G
19 granted patents·16 pending applications·540 citations·filing 1989–2016
95Inventor score
Top patents by PatentIndex Score
35 records- 0196US6034256ASubstituted benzopyran derivatives for the treatment of inflammationSEARLE & CO·Filed 1998·Granted Mar 7, 2000·172 cites·27 claims
- 0295US6077850ASubstituted benzopyran analogs for the treatment of inflammationSEARLE & CO·Filed 1998·Granted Jun 20, 2000·132 cites·14 claims
- 0394US6271253B1Substituted benzopyran derivatives for the treatment of inflammationSEARLE & CO·Filed 2000·Granted Aug 7, 2001·53 cites·14 claims
- 0492US6492390B2Substituted benzopyran analogs for the treatment of inflammationSEARLE & CO·Filed 2001·Granted Dec 10, 2002·38 cites·7 claims
- 0590US7598231B2Tricyclic compound, compositions, and methodsPFIZER·Filed 2008·Granted Oct 6, 2009·13 cites·6 claims
- 0688US5229112ACombatting plant insect pests with plant-colonizing microorganisms containing the toxin gene B. thuringiensis as a chromosomal insertionMONSANTO CO·Filed 1989·Granted Jul 20, 1993·37 cites·32 claims
- 0784US7786097B2Tricyclic compounds, compositions and methodsPFIZER·Filed 2009·Granted Aug 31, 2010·5 cites·8 claims
- 0883US8158660B2Tricyclic compounds, compositions and methodsCHENG HENGMIAO·Filed 2009·Granted Apr 17, 2012·4 cites·8 claims
- 0981US7138411B2Substituted benzopyran derivatives for the treatment of inflammationSEARLE & CO·Filed 2002·Granted Nov 21, 2006·11 cites·8 claims
- 1078US8445520B2Tricyclic compounds, compositions, and methodsCHENG HENGMIAO·Filed 2011·Granted May 21, 2013·2 cites·9 claims
- 1176US7109211B2Substituted benzopyran derivatives for the treatment of inflammationPHARMACIA CORP OF PFIZER INC·Filed 2004·Granted Sep 19, 2006·7 cites·9 claims
- 1275US6806288B1Substituted benzopyran derivatives for the treatmentSEARLE & CO·Filed 2000·Granted Oct 19, 2004·7 cites·23 claims
- 1370US6340705B1Use of α-linolenic acid metabolites for treatment or prevention of cancerMONSANTO TECHNOLOGY LLC·Filed 1999·Granted Jan 22, 2002·37 cites·23 claims
- 1469US9371305B2Deuterated benzopyran compounds and application thereofZHANG YANMEI·Filed 2012·Granted Jun 21, 2016·1 cites·23 claims
- 1562US2014142316A1Tricyclic Compounds, Compositions, And MethodsPFIZER·Filed 2013·Application pending·0 cites
- 1659US5200341AAltered gene and E. coli strains and methods useful in enhanced accumulation of proteinsMONSANTO CO·Filed 1991·Granted Apr 6, 1993·17 cites·9 claims
- 1755US2004185122A1Selective COX-2 inhibition from edible plant extractsPHARMACIA CORP·Filed 2004·Application pending·0 cites
- 1853US9770432B2Deuterated benzopyran compounds and the use in the treatment of pain and inflammationGUANGZHOU INST BIOMED & HEALTH·Filed 2016·Granted Sep 26, 2017·0 cites·37 claims
- 1953US9763914B2Deuterated benzopyran compounds and application thereofGUANGZHOU INST BIOMED & HEALTH·Filed 2016·Granted Sep 19, 2017·0 cites·18 claims
- 2053US2005107387A1Compositions of a cyclooxygenase-2 selective inhibitor and a peroxisome proliferator activated receptor agonist for the treatment of ischemic mediated central nervous system disordersPHARMACIA CORP·Filed 2004·Application pending·0 cites
- 2152US2004197429A1Selective COX-2 inhibition from plant extractsPHARMACIA CORP·Filed 2004·Application pending·0 cites
- 2250US2004003432A1Production of hexosamines and uses thereofPHARMACIA CORP·Filed 2003·Application pending·0 cites
- 2349US2004044028A1Combinations of omega-3 fatty acids and cyclooxygenase-2 inhibitors for treatment or prevention of cardiovascular disease and treatment or prevention of cancerFiled 2002·Application pending·0 cites
- 2449US2004052870A1Selective cox-2 inhibition from edible plant extractsFiled 2001·Application pending·0 cites
- 2548US2004126438A1Selective cox-2 inhibition from plant extractsFiled 2001·Application pending·0 cites
- 2648US2004062823A1Selective cox-2 inhibition from non-edible plant extractsFiled 2001·Application pending·0 cites
- 2748US2001024664A1Selective COX-2 inhibition from edible plant extractsFiled 2000·Application pending·0 cites
- 2847US2002136784A1Selective COX-2 inhibition from plant extractsPHARMACIA CORP·Filed 2001·Application pending·0 cites
- 2946US2002192305A1Inflammatory mediation obtained from atractylodes lanceaMONSANTO CO·Filed 2002·Application pending·0 cites
- 3046US2002010211A1Use of alpha-linolenic acid metabolites for treatment or prevention of cancerFiled 2001·Application pending·0 cites
- 3143US2003212138A1Combinations of peroxisome proliferator-activated receptor-alpha agonists and cyclooxygenase-2 selective inhibitors and therapeutic uses thereforPHARMACIA CORP·Filed 2003·Application pending·0 cites
- 3241US2002122836A1Selective COX-2 inhibition from non-edible plant extractsPHARMACIA CORP·Filed 2001·Application pending·0 cites
- 3333US5395763AChromosomal expression vectorMONSANTO CO·Filed 1992·Granted Mar 7, 1995·4 cites·4 claims
- 3429US2001006686A1Inflammatory mediation obtained from atractylodes lanceaFiled 1999·Application pending·0 cites
- 3523US5814483AExpression of heterologous polypeptides from a mini Mu vectorSEARLE & CO·Filed 1994·Granted Sep 29, 1998·0 cites·6 claims
Join the waitlist — get patent alerts
Get an alert when Mark Obukowicz files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →